ORIC Pharmaceuticals, Inc.
ORIC
$8.60
-$0.23-2.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.25% | 6.39% | 10.36% | -21.10% | 17.31% |
| Total Depreciation and Amortization | -15.63% | 11.11% | -7.10% | 2.65% | -0.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.93% | 19.71% | -15.69% | 5.48% | 58.92% |
| Change in Net Operating Assets | -340.44% | -22.35% | 374.74% | 90.81% | -293.74% |
| Cash from Operations | -44.28% | 10.47% | 18.58% | 5.20% | -15.97% |
| Capital Expenditure | 99.12% | -548.57% | 44.44% | 83.72% | -76.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -204.43% | 115.58% | -43.75% | -436.59% | -46.73% |
| Cash from Investing | -205.83% | 115.37% | -43.68% | -442.67% | -47.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4,042.20% | -98.65% | -17.46% | 53,147.43% | -56.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -320.53% | -71.07% | -- |
| Cash from Financing | 3,976.00% | -98.63% | -18.50% | 1,220,827.27% | -98.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 368.24% | 84.73% | -198.74% | 363.40% | -166.37% |